<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-07306R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0005438</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Physiology/Endocrinology</subject><subject>Diabetes and Endocrinology/Bone and Mineral Metabolism</subject><subject>Rheumatology/Bone and Mineral Metabolism</subject></subj-group></article-categories><title-group><article-title><italic>Lef1</italic> Haploinsufficient Mice Display a Low Turnover and Low Bone Mass Phenotype in a Gender- and Age-Specific Manner</article-title><alt-title alt-title-type="running-head"><italic>Lef1</italic> Regulates Bone Mass</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Noh</surname><given-names>Tommy</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Gabet</surname><given-names>Yankel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cogan</surname><given-names>Jon</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Yunfan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tank</surname><given-names>Archana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sasaki</surname><given-names>Tomoyo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Criswell</surname><given-names>Braden</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dixon</surname><given-names>Alexis</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tam</surname><given-names>Joseph</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kohler</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Segev</surname><given-names>Eran</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kockeritz</surname><given-names>Lisa</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Woodgett</surname><given-names>James</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>M&#x000fc;ller</surname><given-names>Ralph</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chai</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Elisheva</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bab</surname><given-names>Itai</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Frenkel</surname><given-names>Baruch</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Institute for Genetic Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Center for Craniofacial Molecular Biology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Bone Laboratory, Faculty of Dental Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Institute for Biomechanics, ETH Z&#x000fc;rich, Z&#x000fc;rich, Switzerland</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada</addr-line></aff><aff id="aff7"><label>7</label><addr-line>Department of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Giannobile</surname><given-names>William</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Michigan, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>frenkel@usc.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: TN YG ES IB BF. Performed the experiments: TN YG JPC YS AT BC AD CL LK. Analyzed the data: TN YG JPC JT TK ES RM ES IB BF. Contributed reagents/materials/analysis tools: TS LK JRW RM YC. Wrote the paper: TN YG ES IB BF. Co-directed the project: BF IB ES.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>4</day><month>5</month><year>2009</year></pub-date><volume>4</volume><issue>5</issue><elocation-id>e5438</elocation-id><history><date date-type="received"><day>12</day><month>11</month><year>2008</year></date><date date-type="accepted"><day>2</day><month>4</month><year>2009</year></date></history><copyright-statement>Noh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><p>We investigated the role of <italic>Lef1</italic>, one of the four transcription factors that transmit Wnt signaling to the genome, in the regulation of bone mass. Microcomputed tomographic analysis of 13- and 17-week-old mice revealed significantly reduced trabecular bone mass in <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> females compared to littermate wild-type females. This was attributable to decreased osteoblast activity and bone formation as indicated by histomorphometric analysis of bone remodeling. In contrast to females, bone mass was unaffected by <italic>Lef1</italic> haploinsufficiency in males. Similarly, females were substantially more responsive than males to haploinsufficiency in <italic>Gsk3&#x003b2;</italic>, a negative regulator of the Wnt pathway, displaying in this case a high bone mass phenotype. <italic>Lef1</italic> haploinsufficiency also led to low bone mass in males lacking functional androgen receptor (AR) (<italic>tfm</italic> mutants). The protective skeletal effect of AR against Wnt-related low bone mass is not necessarily a result of direct interaction between the AR and Wnt signaling pathways, because <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> female mice had normal bone mass at the age of 34 weeks. Thus, our results indicate an age- and gender-dependent role for <italic>Lef1</italic> in regulating bone formation and bone mass <italic>in vivo</italic>. The resistance to <italic>Lef1</italic> haploinsufficiency in males with active AR and in old females could be due to the reduced bone turnover in these mice.</p></abstract><counts><page-count count="10"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>The wingless/Wnt family of secreted glycoproteins has critical roles in cell growth and differentiation, and is highly conserved among vertebrates, flies, and primitive multicellular organisms <xref ref-type="bibr" rid="pone.0005438-Miller1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Cadigan1">&#x0005b;2&#x0005d;</xref>. In mammals, the canonical Wnt pathway is pivotal to embryogenesis and tumorigenesis as well as in the maintenance and regeneration of tissues such as skin, intestine, liver, cardiac muscle, and the nervous system <xref ref-type="bibr" rid="pone.0005438-Miller1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005438-Tamai1">&#x0005b;7&#x0005d;</xref>. Wnt ligands bind to membrane complexes consisting of a seven transmembrane domain receptor of the frizzled family <xref ref-type="bibr" rid="pone.0005438-Bhanot1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005438-YangSnyder1">&#x0005b;5&#x0005d;</xref> and a &#x02018;single-pass&#x02019; co-receptor, Lipoprotein Receptor-Related Protein 6 (Lrp6) and possibly Lrp5 as well <xref ref-type="bibr" rid="pone.0005438-Pinson1">&#x0005b;6&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005438-Wehrli1">&#x0005b;8&#x0005d;</xref>. In the absence of stimulation, the Wnt pathway is under the negative control of a pair of protein-serine kinases, Glycogen Synthase Kinase 3&#x003b1; and 3&#x003b2; (Gsk3&#x003b1;, Gsk3&#x003b2;), which phosphorylate &#x003b2;-catenin, a Wnt transducer, resulting in its ubiquitination and subsequent proteasomal degradation <xref ref-type="bibr" rid="pone.0005438-Hart1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Itoh1">&#x0005b;10&#x0005d;</xref>. Upon Wnt stimulation, the Gsk3-mediated phosphorylation of &#x003b2;-catenin is attenuated through disruption of the &#x003b2;-catenin destruction complex <xref ref-type="bibr" rid="pone.0005438-Ikeda1">&#x0005b;11&#x0005d;</xref>. Subsequently, &#x003b2;-catenin accumulates and translocates to the nucleus, where it activates Wnt target genes by associating with the DNA-binding HMG box transcription factors lymphoid enhancer factor 1 (Lef1), T-cell factor 7 (Tcf7), Tcf7L1, and/or Tcf7L2 <xref ref-type="bibr" rid="pone.0005438-Travis1">&#x0005b;12&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005438-Korinek1">&#x0005b;15&#x0005d;</xref>. Tcf7, Tcf7L1 and Tcf7L2 are commonly known as Tcf1, Tcf3, and Tcf4, respectively, and these common names are used in this paper.</p><p>Osteoporosis, the most prevalent degenerative disease in western societies, is characterized by decreased bone mass and structural integrity. The mammalian skeleton undergoes continuous turnover, where overall bone gain or loss is determined by the difference between bone resorption and formation. After birth, bone mass increases until it reaches &#x0201c;peak bone mass&#x0201d;, which is then maintained at a constant level during young adulthood, followed by an age-related bone loss <xref ref-type="bibr" rid="pone.0005438-Bab1">&#x0005b;16&#x0005d;</xref>. Bone mass accrual is subject to sexual dimorphism, with males having higher trabecular bone volume density and lower bone turnover than females <xref ref-type="bibr" rid="pone.0005438-Bab1">&#x0005b;16&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005438-Glatt1">&#x0005b;19&#x0005d;</xref>. The age-related bone loss is associated with reduction in turnover rate especially in females <xref ref-type="bibr" rid="pone.0005438-Juttner1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Pantschenko1">&#x0005b;21&#x0005d;</xref>.</p><p>In humans and mice alike, bone mass is strongly dependent on the Wnt signaling pathway <xref ref-type="bibr" rid="pone.0005438-Glass1">&#x0005b;22&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Glass2">&#x0005b;23&#x0005d;</xref>. Mutations and polymorphism in <italic>Wnt10b</italic>, <italic>Dkk1</italic>, <italic>Dkk2</italic>, <italic>Sfrp1</italic>, <italic>Sost</italic>, <italic>Lrp6</italic>, and <italic>Gsk3&#x003b2;</italic> affect osteoblast function and therefore bone formation and bone mass <xref ref-type="bibr" rid="pone.0005438-Holmen1">&#x0005b;24&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005438-Kamiya1">&#x0005b;30&#x0005d;</xref>. The Wnt pathway has also been implicated in mediating positive and negative control of bone formation and bone mass by environmental factors such as pharmacological glucocorticoids <xref ref-type="bibr" rid="pone.0005438-Smith1">&#x0005b;31&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005438-Wang1">&#x0005b;34&#x0005d;</xref> and mechanical stimulation <xref ref-type="bibr" rid="pone.0005438-Armstrong1">&#x0005b;35&#x0005d;</xref>. Interestingly, Wnt signaling in osteoblasts also controls osteoclast activity, as demonstrated by increased resorption and a low bone mass (LBM) phenotype in mice whose osteoblasts lack &#x003b2;-catenin or Tcf1 <xref ref-type="bibr" rid="pone.0005438-Glass2">&#x0005b;23&#x0005d;</xref>. The role of Lef1 in postnatal bone metabolism has not been studied, in part because <italic>Lef1</italic> deficient mice die within the first week of life <xref ref-type="bibr" rid="pone.0005438-vanGenderen1">&#x0005b;36&#x0005d;</xref>.</p><p>During early embryogenesis, Tcf1 and Lef1 are redundant. Mice lacking both genes have multiple defects, including duplicated neural tubes and malformed limb buds, whereas mice lacking either gene alone do not exhibit these defects <xref ref-type="bibr" rid="pone.0005438-Galceran1">&#x0005b;37&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Okamura1">&#x0005b;38&#x0005d;</xref>. Non-redundant functions of these transcription factors are suggested by the distinct phenotypes observed in mice lacking either Tcf1 or Lef1. Whereas <italic>Tcf1</italic>-null mice display attenuated T cell differentiation <xref ref-type="bibr" rid="pone.0005438-Staal1">&#x0005b;39&#x0005d;</xref>, <italic>Lef1</italic>-null mice exhibit developmental defects in teeth, hair follicles, mammary glands and the brain <xref ref-type="bibr" rid="pone.0005438-vanGenderen1">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Galceran2">&#x0005b;40&#x0005d;</xref>. In terms of skeletal metabolism, analysis of <italic>Tcf1</italic>-null mice disclosed accelerated bone resorption <xref ref-type="bibr" rid="pone.0005438-Glass2">&#x0005b;23&#x0005d;</xref>, but similar analysis of <italic>Lef1</italic>-null mice is hampered by their perinatal lethality. In this study, we employed the viable <italic>Lef1</italic> haploinsufficient mice, which do not display the abnormalities observed in the null mice, to assess the role of <italic>Lef1</italic> in postnatal bone metabolism. We demonstrate a low bone mass phenotype in <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> mice, which appears to manifest specifically in the context of high bone turnover rate.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Low bone mass (LBM) phenotype in <italic>Lef1</italic> heterozygous female mice</title><p>Micro-computed tomographic (&#x003bc;CT) analysis of 13-week old <italic>Lef1</italic> haploinsufficient female mice revealed a LBM phenotype compared to littermate controls (<xref ref-type="fig" rid="pone-0005438-g001">Figure 1</xref>). The trabecular bone volume density (BV/TV) measured in the distal femur (<xref ref-type="fig" rid="pone-0005438-g001">Figure 1A</xref>) and the vertebral body (<xref ref-type="fig" rid="pone-0005438-g001">Figure 1C</xref>) of <italic>Lef1</italic> haploinsufficient mice was 34&#x00025; and 17&#x00025; lower than the wild-type (WT) controls, respectively. In contrast to females, male mice showed no difference between <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> and WT animals (<xref ref-type="fig" rid="pone-0005438-g001">Figure 1</xref>). The decrease in BV/TV due to <italic>Lef1</italic> haploinsufficiency resembles the magnitude of trabecular bone loss due to <italic>Lrp6</italic> haploinsufficiency <xref ref-type="bibr" rid="pone.0005438-Holmen1">&#x0005b;24&#x0005d;</xref>.</p><fig id="pone-0005438-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005438.g001</object-id><label>Figure 1</label><caption><title>Low trabecular bone mass in <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> female mice.</title><p>(A,C) &#x003bc;CT analysis of the distal femoral (A) and the vertebral (C) trabecular bone of <italic>Lef1<sup>&#x0002b;/&#x0002b;</sup> (black)</italic> and <italic>Lef1<sup>&#x0002b;/&#x02212;</sup> (white)</italic> female (<italic>left</italic>) and male (<italic>right</italic>) 13-week old mice. BV/TV &#x02013; trabecular bone volume density, Tb.N &#x02013; trabecular number, Tb.Th &#x02013; trabecular thickness, Conn.D &#x02013; connectivity density (Mean&#x000b1;SEM of 4&#x02013;10 specimens as indicated within the bars at the top, &#x0002a;&#x0200a;&#x0003d;&#x0200a;<italic>p</italic>&#x0003c;0.05). (B,D) &#x003bc;CT images of distal femoral (B) and vertebral (D) trabecular bone of female (<italic>left</italic>) and male (<italic>right</italic>) 13-week old mice with median BV/TV. Scale bar&#x0200a;&#x0003d;&#x0200a;0.5 mm.</p></caption><graphic xlink:href="pone.0005438.g001"/></fig><p>Detailed analysis of the trabecular bone parameters in the 13-week old female mice revealed interesting site-specific responses to <italic>Lef1</italic> haploinsufficiency. While the decreased BV/TV at the vertebral bodies was attributable to thinning of trabeculae, the LBM at the distal femoral metaphysis was due to decreased trabecular number (Tb.N) and was also associated with decreased connectivity density (Conn.D, <xref ref-type="fig" rid="pone-0005438-g001">Figure 1</xref>). Skeletal site-specific control of bone mass, both related and unrelated to the Wnt signaling pathway, has been previously observed <xref ref-type="bibr" rid="pone.0005438-Bennett1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Babij1">&#x0005b;41&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005438-Wu1">&#x0005b;44&#x0005d;</xref>, although the underlying mechanisms remain to be elucidated. A similar trabecular bone phenotype was observed in 17-week old <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> females, and again males were unaffected. At 13 weeks of age, the <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> females, but not males, also exhibited reduced cortical bone thickness (0.162 mm <italic>vs.</italic> 0.188 mm in wild-type females, p&#x0200a;&#x0003d;&#x0200a;0.021), but the femoral length and mid-diaphyseal diameter were unaffected by the <italic>Lef1</italic> gene dosage in either gender (data not shown). Additionally, we did not detect any skeletal abnormalities in <italic>Lef1</italic> knockout newborns, as indicated by whole mount staining and histological analysis (<xref ref-type="supplementary-material" rid="pone.0005438.s001">Figure S1</xref>). The total body weight was similar in <italic>Lef1</italic> heterozygous and gender/age-matched WT controls (data not shown). Thus, <italic>Lef1</italic> haploinsufficiency leads to a LBM phenotype specifically in females, demonstrating for the first time a role for <italic>Lef1</italic> in bone metabolism.</p></sec><sec id="s2b"><title>Decreased bone formation in <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> female mice</title><p>Wnt signaling has been implicated in both promoting osteoblast <xref ref-type="bibr" rid="pone.0005438-Hill1">&#x0005b;45&#x0005d;</xref> and attenuating osteoclast function <xref ref-type="bibr" rid="pone.0005438-Glass2">&#x0005b;23&#x0005d;</xref>. Accordingly, <italic>Lef1</italic> haploinsufficiency could lead to a LBM phenotype by either inhibiting bone formation or stimulating bone resorption. We therefore assessed trabecular bone formation and resorption in distal femoral metaphyses of 17-week old <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> mice and littermate controls using vital calcein labeling and TRAP staining, respectively. As shown in <xref ref-type="fig" rid="pone-0005438-g002">Figure 2C</xref>, <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> female mice exhibited a 25&#x00025; lower bone formation rate (BFR) as compared to WT controls (<xref ref-type="fig" rid="pone-0005438-g002">Figure 2C</xref>), attributable mainly to decreased mineral apposition rate (MAR; <xref ref-type="fig" rid="pone-0005438-g002">Figure 2A</xref>), which represents the activity of the average osteoblast. Thus, the female <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> LBM phenotype is attributable to reduced osteoblast function. In contrast, there was no indication for increased bone resorption in <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> females because they had less, not more TRAP-positive cells compared to controls (<xref ref-type="fig" rid="pone-0005438-g002">Figure 2D</xref>). Importantly, the skeletal remodeling analysis in male mice revealed no difference between <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> and <italic>Lef1</italic><sup>&#x0002b;/&#x0002b;</sup> animals (<xref ref-type="fig" rid="pone-0005438-g002">Figure 2</xref>). On a side note, our findings demonstrate lower bone turnover in WT male compared to WT female mice (&#x02212;42.1&#x00025; MAR; &#x02212;51.4&#x00025; BFR and &#x02212;45.6&#x00025; osteoclast number, <italic>p</italic>&#x0003c;0.05 for each parameter), which is consistent with previous reports <xref ref-type="bibr" rid="pone.0005438-DeMambro1">&#x0005b;46&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Pennypacker1">&#x0005b;47&#x0005d;</xref>. The higher bone turnover in females compared to males may predispose the formers to <italic>Lef1</italic> haploinsufficiency-induced LBM (see below).</p><fig id="pone-0005438-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005438.g002</object-id><label>Figure 2</label><caption><title>Low bone formation in <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> female mice.</title><p>Histomorphometric analysis of the distal femoral metaphysis from <italic>Lef1</italic><sup>&#x0002b;/&#x0002b;</sup> (<italic>black</italic>) and <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> (<italic>white</italic>) female (<italic>left</italic>) and male (<italic>right</italic>) 17-week old mice. (A) mineral apposition rate (MAR), a surrogate for osteoblast activity; images show representative histological sections from <italic>Lef1</italic><sup>&#x0002b;/&#x0002b;</sup> (<italic>left</italic>) and <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> (<italic>right</italic>) females; (B) mineralizing perimeter (Min.Peri), a surrogate for osteoblast number; (C) bone formation rate (BFR); (D) trabecular bone osteoclast number (N.Oc/BS). Data represent mean&#x000b1;SEM of 4&#x02013;9 specimens as indicated within the bars in A; &#x0002a;&#x0200a;&#x0003d;&#x0200a;<italic>p</italic>&#x0003c;0.05.</p></caption><graphic xlink:href="pone.0005438.g002"/></fig><p>We next assessed the effects of <italic>Lef1</italic> heterozygocity on Lef1 expression and on osteoblast differentiation <italic>in vitro</italic>. First, we confirmed that Lef1 expression was significantly reduced in bones and in newborn mouse calvarial osteoblast (NeMCO) cultures derived from <italic>Lef1</italic> heterozygous compared to control mice (<xref ref-type="fig" rid="pone-0005438-g003">Figure 3A&#x02013;3C</xref>). In mesenchymal stem cell (MSC) cultures derived from bone marrow of female mice, <italic>Lef1</italic> haploinsufficiency increased the number of CFU-F, whereas the number of CFU-Ob was unchanged (<xref ref-type="fig" rid="pone-0005438-g003">Figure 3D</xref>). Interestingly, <italic>Lef1</italic> haploinsufficiency in male mice, which did not reduce bone mass <italic>in vivo</italic> (<xref ref-type="fig" rid="pone-0005438-g001">Figure 1</xref>), was associated with an increase in bone marrow-derived CFU-Ob (<xref ref-type="fig" rid="pone-0005438-g003">Figure 3D</xref>). <italic>In vitro</italic> osteoblast differentiation as defined by mineralization in NeMCO cultures was accelerated by <italic>Lef1</italic> haploinsufficiency (<xref ref-type="fig" rid="pone-0005438-g003">Figure 3E</xref>).</p><fig id="pone-0005438-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005438.g003</object-id><label>Figure 3</label><caption><title>Reduced Lef1 expression is not associated with impaired osteoblast differentiation <italic>in vitro</italic>.</title><p>(A,B) Lef1 mRNA in tibia of <italic>Lef1</italic><sup>&#x0002b;/&#x02212;</sup> and control male and female mice (A) and in NeMCO cultures (B) was assessed by RT-qPCR and corrected for the expression of GAPDH and rpL10A, respectively. Bars represent relative expression levels (Mean&#x000b1;SEM, n&#x0200a;&#x0003d;&#x0200a;3). (C) Western blot analysis of Lef1 expression in NeMCO cultures. Equal loading was demonstrated by Coomassie blue staining (bottom panel shows a &#x0223c;60 KDa Coomassie blue-stained band). (D) Bone marrow mesenchymal cells from WT and <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> mice of each gender were cultured for 28 days, fixed and stained with Alizarin red. Colonies were manually counted in each of 6&#x02013;11 independent cultures for each condition. Alizarin red-positive colonies were counted as osteoblastic colony-forming units (CFU-Ob), and the rest were considered fibroblastic CFU (CFU-F). (E) Day-20 NeMCO cultures from WT and <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> mice were fixed and stained with Alizarin red. Data represent mean mineralized area relative to WT&#x000b1;SEM in at least 3 cultures per condition. &#x0002a;&#x0200a;&#x0003d;&#x0200a;<italic>p</italic>&#x0003c;0.05 <italic>vs.</italic> WT.</p></caption><graphic xlink:href="pone.0005438.g003"/></fig></sec><sec id="s2c"><title>High bone mass (HBM) in <italic>Gsk3&#x003b2;</italic> haploinsufficient female mice</title><p>Alterations in components of the Wnt pathway other than Lef1 may also have stronger skeletal effects in females as compared to males. To address this notion, we compared the role of Gsk3&#x003b2;, a negative regulator of the Wnt pathway, in female <italic>versus</italic> male bone mass. Because the <italic>Gsk3&#x000df;</italic>-null mice die <italic>in utero</italic><xref ref-type="bibr" rid="pone.0005438-Hoeflich1">&#x0005b;48&#x0005d;</xref>, we analyzed the trabecular bone in the distal femoral metaphysis of mice haploinsufficient for <italic>Gsk3&#x000df;</italic>. Indeed, female, but not male <italic>Gsk3&#x003b2;</italic><sup>&#x0002b;/&#x02212;</sup> mice exhibited a high bone mass (HBM) phenotype compared to WT littermates (<xref ref-type="fig" rid="pone-0005438-g004">Figure 4A</xref>). The elevated BV/TV was attributable to increased trabecular number, and was associated with increased connectivity density (<xref ref-type="fig" rid="pone-0005438-g004">Figure 4</xref>), a mirror image of the respective <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> LBM phenotype. Jointly, the gender-preferential effects of both <italic>Lef1</italic> and <italic>Gsk3&#x003b2;</italic> haploinsufficiency suggest that the skeleton is more sensitive to variations in Wnt signaling in females compared to males.</p><fig id="pone-0005438-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005438.g004</object-id><label>Figure 4</label><caption><title>High trabecular bone mass in <italic>Gsk3&#x003b2;</italic><sup>&#x0002b;/&#x02212;</sup> female mice.</title><p>(A) &#x003bc;CT analysis of the distal femoral trabecular bone of 16 week old <italic>Gsk3&#x003b2;</italic><sup>&#x0002b;/&#x0002b;</sup> (<italic>black</italic>) and <italic>Gsk3&#x003b2;</italic><sup>&#x0002b;/&#x02212;</sup> (<italic>white</italic>) female (<italic>left</italic>) and male (<italic>right</italic>) mice. Data represent mean&#x000b1;SEM of 6&#x02013;14 specimens as indicated within the bars at the top, &#x0002a;&#x0200a;&#x0003d;&#x0200a;<italic>p</italic>&#x0003c;0.05. (B) &#x003bc;CT images from female (<italic>left</italic>) and male (<italic>right</italic>) mice with median BV/TV. Scale bar&#x0200a;&#x0003d;&#x0200a;0.5 mm.</p></caption><graphic xlink:href="pone.0005438.g004"/></fig></sec><sec id="s2d"><title>Androgen signaling protects against <italic>Lef1</italic> haploinsufficiency</title><p>The female-preferential skeletal phenotype of the <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> mice could be explained by a compensatory gene(s) on the Y chromosome, hypersensitization by estrogens, or protection by androgens. In support of the latter possibility, androgens can augment Wnt signaling <xref ref-type="bibr" rid="pone.0005438-Liu1">&#x0005b;49&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Liu2">&#x0005b;50&#x0005d;</xref>, and even stimulate Lef1 expression in osteoblasts (<xref ref-type="supplementary-material" rid="pone.0005438.s002">Figure S2</xref>) similar to what has been observed in adipocytes <xref ref-type="bibr" rid="pone.0005438-Singh1">&#x0005b;51&#x0005d;</xref>. To test the hypothesis that androgen signaling protects against <italic>Lef1</italic> haploinsufficiency-induced LBM <italic>in vivo</italic>, we employed <italic>tfm</italic> male mice, in which androgen signaling is absent due to a naturally occurring mutation in the androgen receptor (AR) <xref ref-type="bibr" rid="pone.0005438-Lyon1">&#x0005b;52&#x0005d;</xref>. To generate <italic>Lef1</italic><sup>&#x0002b;/&#x02212;</sup>;<italic>AR<sup>tfm</sup></italic> mice, <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> males were bred with female <italic>tfm</italic> carriers. Because the <italic>AR<sup>tfm</sup></italic> allele is embedded in a tabby genomic sequence <xref ref-type="bibr" rid="pone.0005438-Lyon2">&#x0005b;53&#x0005d;</xref>, we first analyzed the distal femora in offspring with wild type AR, but which are no longer on a pure C57BL/6 background. Similar to the original results (<xref ref-type="fig" rid="pone-0005438-g001">Figure 1</xref>), female <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> mice that partially carry the tabby genome exhibited a LBM phenotype (<xref ref-type="fig" rid="pone-0005438-g005">Figure 5Aa</xref>, and compare <xref ref-type="fig" rid="pone-0005438-g005">Figure 5Ba to 5Bb</xref>), while male mice on the same genetic background were protected (<xref ref-type="fig" rid="pone-0005438-g005">Figure 5Ac</xref>, and compare <xref ref-type="fig" rid="pone-0005438-g005">Figure 5Be to 5Bf</xref>). Remarkably, however, male <italic>tfm</italic> mice were vulnerable to <italic>Lef1</italic> haploinsufficiency, similar to females (<xref ref-type="fig" rid="pone-0005438-g005">Figure 5</xref>). Specifically, <italic>Lef1</italic><sup>&#x0002b;/&#x02212;</sup>;<italic>AR<sup>tfm</sup></italic> mice had a 22&#x00025; lower BV/TV as compared to their <italic>Lef1</italic><sup>&#x0002b;/&#x0002b;</sup>;<italic>AR<sup>tfm</sup></italic> counterparts (<xref ref-type="fig" rid="pone-0005438-g005">Figure 5Ad</xref>, and compare <xref ref-type="fig" rid="pone-0005438-g005">Figure 5Bg to 5Bh</xref>). Similar results were observed in the vertebral bodies (<xref ref-type="fig" rid="pone-0005438-g005">Figure 5C and 5D</xref>). Because estrogen levels in <italic>tfm</italic> males do not approach those of females <xref ref-type="bibr" rid="pone.0005438-Vandenput1">&#x0005b;54&#x0005d;</xref>, and because these mice still carry an intact Y chromosome, these results demonstrate that androgen signaling protects against <italic>Lef1</italic> haploinsufficiency-induced LBM.</p><fig id="pone-0005438-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005438.g005</object-id><label>Figure 5</label><caption><title>Androgen signaling protects against <italic>Lef1</italic> haploinsufficiency-induced low bone mass.</title><p>&#x003bc;CT analysis of the trabecular bone compartment in distal femora (A,B) and vertebral bodies (C,D) of 13-week old female (<italic>left</italic>) and male (<italic>right</italic>) <italic>Lef1</italic><sup>&#x0002b;/&#x0002b;</sup><italic>(black)</italic> and <italic>Lef1<sup>&#x0002b;/&#x02212;</sup> (white)</italic> mice. <italic>AR<sup>tfm</sup></italic> males have no functional AR, while <italic>AR<sup>tfm</sup></italic> females are carriers for the defective <italic>AR</italic> allele. Data represent mean&#x000b1;SEM of 9&#x02013;20 specimens as indicated within the bars at the top, &#x0002a;&#x0200a;&#x0003d;&#x0200a;<italic>p</italic>&#x0003c;0.05. (B) and (D) show respective &#x003bc;CT images of female (<italic>left</italic>) and male (<italic>right</italic>) mice with median BV/TV. Mice in a, b, e and f carry the wild-type AR (<italic>AR<sup>WT</sup></italic>); mice in c, d, g and h carry the <italic>AR<sup>tfm</sup></italic> allele; mice in a, c, e and g are <italic>Lef1</italic><sup>&#x0002b;/&#x0002b;</sup>; mice in b, d, f and h are <italic>Lef1</italic><sup>&#x0002b;/&#x02212;</sup>. Scale bar&#x0200a;&#x0003d;&#x0200a;0.5 mm.</p></caption><graphic xlink:href="pone.0005438.g005"/></fig></sec><sec id="s2e"><title>Aged females are resistant to <italic>Lef1</italic> haploinsufficiency-induced LBM</title><p>It has been previously suggested that androgen signaling can augment Wnt signaling in bone cells <xref ref-type="bibr" rid="pone.0005438-Liu1">&#x0005b;49&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Liu2">&#x0005b;50&#x0005d;</xref>. This could explain how males are protected against <italic>Lef1</italic> haploinsufficiency-induced LBM. Alternatively, androgens could also indirectly protect males by restraining bone turnover <xref ref-type="bibr" rid="pone.0005438-Vandenput1">&#x0005b;54&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Matsumoto1">&#x0005b;55&#x0005d;</xref>. If low bone turnover protects male mice from <italic>Lef1</italic> haploinsufficiency, then <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> females may no longer display a low bone mass phenotype compared to WT females at ages older than 17 weeks, when bone turnover decreases <xref ref-type="bibr" rid="pone.0005438-Juttner1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Pantschenko1">&#x0005b;21&#x0005d;</xref>. Indeed, &#x003bc;CT analysis of 34-week old female mice revealed no difference between <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> and WT females (<xref ref-type="fig" rid="pone-0005438-g006">Figure 6</xref>). At this age, the male skeleton was again unaffected by <italic>Lef1</italic> haploinsufficiency (<xref ref-type="fig" rid="pone-0005438-g006">Figure 6</xref>). In summary, <italic>Lef1</italic> haploinsufficiency induces LBM in a gender- and age-specific manner.</p><fig id="pone-0005438-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005438.g006</object-id><label>Figure 6</label><caption><title>Thirty four-week old female mice are insensitive to <italic>Lef1</italic> haploinsufficiency.</title><p>(A,B) &#x003bc;CT analysis of the distal femoral (A) and the vertebral (B) trabecular bone of <italic>Lef1<sup>&#x0002b;/&#x0002b;</sup> (black)</italic> and <italic>Lef1<sup>&#x0002b;/&#x02212;</sup> (white)</italic> female (<italic>left</italic>) and male (<italic>right</italic>) 34-week old mice (Data represent mean&#x000b1;SEM of 7&#x02013;11 specimens as indicated within the bars at the top).</p></caption><graphic xlink:href="pone.0005438.g006"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>The present work demonstrates low bone mass in mice, in which one <italic>Lef1</italic> gene copy is disrupted. Interestingly, bone mass was reduced in 13- and 17-week old females, but not in males of any age or in 34-week old females. This gender-specificity reflected neither protection by a Y chromosome-associated gene nor sensitization by estrogens, since <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> male mice harboring a testicular feminization mutation (<italic>tfm</italic>) also displayed a LBM phenotype despite their having an intact Y chromosome and not having feminine estrogen levels <xref ref-type="bibr" rid="pone.0005438-Vandenput1">&#x0005b;54&#x0005d;</xref>. <italic>Gsk3&#x003b2;<sup>&#x0002b;/&#x02212;</sup></italic> mice displayed a mirror image of the <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> phenotype, namely increased bone mass in female mice only. In line with our findings, disruption of <italic>Sfrp1</italic>, a Wnt antagonist, resulted in a female-preferential bone phenotype <xref ref-type="bibr" rid="pone.0005438-Bodine1">&#x0005b;29&#x0005d;</xref>. Thus, genetic alterations in components of the Wnt pathway appear to affect female more than male mice. That <italic>Lrp5</italic> deficiency reduces bone mass equally in males and females <xref ref-type="bibr" rid="pone.0005438-Dubrow1">&#x0005b;56&#x0005d;</xref> is not inconsistent with our conclusion in light of the recent work of Yadav et <italic>al.</italic><xref ref-type="bibr" rid="pone.0005438-Yadav1">&#x0005b;57&#x0005d;</xref>, who disputed the paradigm that places Lrp5 upstream of Gsk3&#x003b2; and Lef1 in osteoblasts. Plausibly, a genetic lesion at the level of <italic>Lef1</italic> itself compromises canonical Wnt signaling and is therefore more consequential in females than in males.</p><p>All mice that were sensitive to <italic>Lef1</italic> haploinsufficiency in our study, namely young females and <italic>tfm</italic> males, are also characterized by a relatively high rate of bone turnover (<xref ref-type="fig" rid="pone-0005438-g002">Figure 2</xref> and ref. <xref ref-type="bibr" rid="pone.0005438-Vandenput1">&#x0005b;54&#x0005d;</xref>). In contrast, mice resistant to <italic>Lef1</italic> haploinsufficiency&#x02014;<italic>AR</italic><sup>WT</sup> males and aged females (<xref ref-type="fig" rid="pone-0005438-g001">Figure 1</xref>, <xref ref-type="fig" rid="pone-0005438-g005">Figure 5</xref>, <xref ref-type="fig" rid="pone-0005438-g006">Figure 6</xref>)&#x02014;have a lower rate of bone turnover (<xref ref-type="fig" rid="pone-0005438-g002">Figure 2</xref> and <xref ref-type="bibr" rid="pone.0005438-Juttner1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Pantschenko1">&#x0005b;21&#x0005d;</xref>). Thus, a unifying explanation for our observations is that bone turnover rate determines the skeletal response to genetic alterations in canonical Wnt signaling. Our favored interpretation of the gender-specific sensitivity to <italic>Lef1</italic> haploinsufficiency is that androgens protect the skeleton from the potential deleterious effect of reduced <italic>Lef1</italic> by restraining bone turnover <xref ref-type="bibr" rid="pone.0005438-Vandenput1">&#x0005b;54&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Matsumoto1">&#x0005b;55&#x0005d;</xref>.</p><p>We cannot rule out an alternative explanation whereby AR activity compensates for <italic>Lef1</italic> haploinsufficiency via molecular interaction with the canonical Wnt pathway. In fact, it has been shown that DHT stimulates Lef/Tcf-mediated transcription in osteoblasts <xref ref-type="bibr" rid="pone.0005438-Liu1">&#x0005b;49&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Liu2">&#x0005b;50&#x0005d;</xref>. This could occur via physical interaction of liganded AR with &#x003b2;-catenin <xref ref-type="bibr" rid="pone.0005438-Singh1">&#x0005b;51&#x0005d;</xref> or with membrane residents such as Src <xref ref-type="bibr" rid="pone.0005438-Migliaccio1">&#x0005b;58&#x0005d;</xref>, which could then impinge on the Wnt pathway through activation of the PI3 kinase/Akt/Gsk3&#x003b2; axis <xref ref-type="bibr" rid="pone.0005438-Liu2">&#x0005b;50&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Kang1">&#x0005b;59&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Smith2">&#x0005b;60&#x0005d;</xref>. Alternatively, androgens could regulate the expression of either Lef1 itself (<xref ref-type="supplementary-material" rid="pone.0005438.s002">Figure S2</xref> and <xref ref-type="bibr" rid="pone.0005438-Singh1">&#x0005b;51&#x0005d;</xref>) or Wnt agonists and/or antagonists <xref ref-type="bibr" rid="pone.0005438-Nantermet1">&#x0005b;61&#x0005d;</xref>. However, the normal bone phenotype observed in 34-week old <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> female mice favors the hypothesis that androgen signaling, much like aging in females, overrides the skeletal sensitivity to <italic>Lef1</italic> haploinsufficiency by restraining bone turnover. Obviously, the two explanations for AR-mediated protection against <italic>Lef1</italic> haploinsufficiency &#x02013; molecular interaction with the Wnt pathway and attenuation of bone turnover &#x02013; are not mutually exclusive.</p><p>It remains to be examined to what extent the effect of Lef1 on bone formation is cell autonomous. In favor of cell autonomy is the reduced Lef1 expression in <italic>Lef1</italic><sup>&#x0002b;/&#x02212;</sup> osteoblasts and the observed gender-dependent changes in the numbers of CFU-F and CFU-Ob in bone marrow-derived MSCs cultures (<xref ref-type="fig" rid="pone-0005438-g003">Figure 3D</xref>). Possibly, <italic>Lef1</italic> haploinsufficiency promotes premature osteoblast differentiation (<xref ref-type="bibr" rid="pone.0005438-Kahler1">&#x0005b;62&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Kahler2">&#x0005b;63&#x0005d;</xref> and <xref ref-type="fig" rid="pone-0005438-g003">Figure 3E</xref>). However, much like the effect of duodenal Lrp5 <xref ref-type="bibr" rid="pone.0005438-Yadav1">&#x0005b;57&#x0005d;</xref>, the role of Lef1 in regulating bone formation may reside in cells other than osteoblasts. Cell type-specific knockout studies will be necessary to clarify this issue.</p><p>An intriguing, albeit speculative, extrapolation from our findings is that females reach lower peak bone mass than males because, in the absence of androgens, higher rate of bone turnover renders the young female skeleton more vulnerable to sub-optimal activity of canonical Wnt signaling and possibly other pathways. Other investigators reported on age- and gender-dependent bone phenotypes in mice with genetic alterations in different pathways. For example, osteoblast-specific disruption of BMP type-IA receptor leads to LBM in young mice but HBM in old mice <xref ref-type="bibr" rid="pone.0005438-Mishina1">&#x0005b;64&#x0005d;</xref>. Very similar age-dependent effects were reported for <italic>Runx2</italic> haploinsufficiency in mice <xref ref-type="bibr" rid="pone.0005438-Juttner1">&#x0005b;20&#x0005d;</xref>. In addition, the strong anabolic effect of estrogen in young <italic>Runx2</italic><sup>&#x0002b;/&#x02212;</sup> mice was almost completely abolished in aged mice <xref ref-type="bibr" rid="pone.0005438-Juttner1">&#x0005b;20&#x0005d;</xref>. With regard to gender specificity, and in addition to the female-preferential response to genetic manipulation of <italic>Lef1</italic>, <italic>GSK3&#x000df;</italic> and <italic>Sfrp1</italic>, ablation of <italic>Cathepsin K</italic> results in a 3-fold stronger effect in female compared to male mice <xref ref-type="bibr" rid="pone.0005438-Pennypacker1">&#x0005b;47&#x0005d;</xref>. Age- and gender-related variations in bone turnover may explain the differential skeletal responses to some of these and other genetic aberrations. Furthermore, hormonal and age-related variation in bone turnover may contribute to gender- and age-related susceptibility to osteoporosis and response to therapies.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Animals</title><p><italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> and <italic>Gsk3&#x003b2;</italic><sup>&#x0002b;/&#x02212;</sup> mice and their controls, all on a C57BL/6 background, were generated by breeding <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic><xref ref-type="bibr" rid="pone.0005438-vanGenderen1">&#x0005b;36&#x0005d;</xref> or <italic>Gsk3&#x003b2;</italic><sup>&#x0002b;/&#x02212;</sup><xref ref-type="bibr" rid="pone.0005438-Kugimiya1">&#x0005b;26&#x0005d;</xref> mice with C57BL/6 mice from either Harlan Laboratories (Indianapolis, Indiana, USA) or the Ontario Cancer Institute (Toronto, Canada), respectively. Mice carrying the testicular feminization mutation (<italic>Tfm</italic>) (Jackson Laboratories, Bar Harbor, Maine, USA) on a C57BL/6J<italic>-A-Ta&#x0003c;6J&#x0003e;</italic> background were bred with the <italic>Lef1<sup>&#x0002b;/&#x02212;</sup></italic> mice and F1 litters were examined. To measure the percentage of bone surface undergoing mineralization and the mineralization rate, mice were injected intraperitoneally with 15 mg/kg of the fluorochrome calcein (Sigma-Aldrich, St. Louis, MO, USA) four days and again one day prior to sacrifice. One femur and the fifth lumbar vertebra (L5) from each mouse were dissected and fixed in 10&#x00025; phosphate-buffered formalin (pH&#x0200a;&#x0003d;&#x0200a;7.2) for 24 hours, and then stored in 70&#x00025; ethanol. All experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Southern California and of the University of Toronto.</p></sec><sec id="s4b"><title>Micro-computed tomography</title><p>Femora (one per mouse) and fifth lumbar vertebrae (L5) were examined as reported previously <xref ref-type="bibr" rid="pone.0005438-Bajayo1">&#x0005b;65&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005438-Yirmiya1">&#x0005b;66&#x0005d;</xref> using either Scanco &#x003bc;CT 40 (Scanco Medical AG, Br&#x000fc;ttisellen, Switzerland), or Siemens MicroCAT II (Siemens Medical Solutions, Knoxville, TN, USA). Briefly, scans were performed at a 20-&#x000b5;m resolution in all three spatial dimensions. The mineralized tissues were differentially segmented by a global thresholding procedure <xref ref-type="bibr" rid="pone.0005438-Ruegsegger1">&#x0005b;67&#x0005d;</xref>. Trabecular parameters in the secondary spongiosa of the distal femoral metaphysis included trabecular bone volume density (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N) and connectivity density (Conn.D). Cortical thickness, diaphyseal diameter, and medullary cavity diameter were determined in the mid-diaphyseal region. In L5 bodies, the entire trabecular bone compartment was analyzed. All morphometric parameters were determined by using a direct 3D approach <xref ref-type="bibr" rid="pone.0005438-Hildebrand1">&#x0005b;68&#x0005d;</xref>. Differences between groups were analyzed by student's <italic>t</italic>-test (two-tailed) and were considered significant when <italic>p</italic>&#x0003c;0.05.</p></sec><sec id="s4c"><title>Histomorphometry</title><p>After &#x003bc;CT image acquisition, femora were embedded undecalcified in polymethylmethacrylate (Technovit 9100, Heraeus Kulzer, Germany). Undeplasticized longitudinal 5-&#x000b5;m sections from the center of each bone were left unstained for dynamic histomorphometric measurements. To identify osteoclasts, consecutive sections were deplasticized and stained with tartrate-resistant acid phosphatase (TRAP; Sigma-Aldrich, St. Louis, MO, USA) and counterstained with Mayer's hematoxylin <xref ref-type="bibr" rid="pone.0005438-Erlebacher1">&#x0005b;69&#x0005d;</xref>. The morphometric analysis was performed using the Image-Pro Discovery software (Media Cybernetics, Silver Spring, MD, USA). The following parameters were determined: mineral apposition rate (MAR), mineralizing perimeter (Min.Peri), bone formation rate (BFR) and osteoclast number (N.Oc/BS). The terminology and units used for these measurements were according to the convention of standardized nomenclature <xref ref-type="bibr" rid="pone.0005438-Parfitt1">&#x0005b;70&#x0005d;</xref>. Statistical analysis was performed as above.</p></sec><sec id="s4d"><title>Tissue culture</title><p>NeMCO cultures were prepared from one day-old pups as described previously <xref ref-type="bibr" rid="pone.0005438-Leclerc2">&#x0005b;71&#x0005d;</xref>. Cells were cultured in 6-well plates for Western blot analysis and in 12-well plates for RT-qPCR and mineralization assays. For the latter, osteogenic medium containing ascorbic acid (50 &#x000b5;g/mL) and &#x003b2;-glycerophosphate (10 mM) was initiated at confluence and alizarin red staining was performed at day 20. For MSC cultures, the cellular content of the bone marrow cavity from two femurs and two tibiae from each mouse was flushed using &#x003b1;MEM and passed through needles with decreasing diameters (down to 25G) to obtain a single cell suspension. Cells were then plated at 3&#x000d7;10<sup>6</sup> per well in 6-well plates and incubated for 3 days in &#x003b1;MEM (Invitrogen) supplemented with 15&#x00025; FBS (Gemini Bio-Products, West Sacramento, CA). Starting at day 3, the MSC were cultured in osteogenic medium and stained with Alizarin red after 28 days.</p></sec><sec id="s4e"><title>Lef1 expression</title><p>Total RNA was extracted from freshly isolated tibiae of 10 week-old mice. Upon harvesting, one tibia per animal was stabilized in RNA<italic>Later</italic> (Ambion, Austin, TX), homogenized in Trizol (Invitrogen), purified using 1-Bromo-3-Chloropropane and isopropanol, then rinsed in 70&#x00025; ethanol. RNA from cells was extracted using Aurum Total RNA Mini Kit (Biorad, Hercules, CA). cDNA was produced using Superscript III First Strand cDNA synthesis kit (Invitrogen) and Real-Time PCR was performed using iQ SYBR green supermix (Biorad) and an Opticon 2 real time PCR machine (Biorad). Lef1 mRNA levels in tibiae and NeMCO cultures were corrected for GAPDH and ribosomal protein L10A (rpL10A) mRNA, respectively. Primers used for PCR are listed in <xref ref-type="table" rid="pone-0005438-t001">Table 1</xref>. Western blot analysis of Lef1 in NeMCO cultures was performed essentially as previously described <xref ref-type="bibr" rid="pone.0005438-Leclerc2">&#x0005b;71&#x0005d;</xref> using anti-Lef1 antibody from Cell Signaling (Danvers, MA) and secondary antibodies from Santa Cruz Biotechnology (Santa Cruz, CA).</p><table-wrap id="pone-0005438-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005438.t001</object-id><label>Table 1</label><caption><title>Primers for genotyping and RT&#x02013;qPCR.</title></caption><graphic id="pone-0005438-t001-1" xlink:href="pone.0005438.t001"/><table frame="hsides" rules="groups" alternate-form-of="pone-0005438-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><tbody><tr><td colspan="3" align="left" rowspan="1"><bold>Genotyping</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Lef1</td><td align="left" rowspan="1" colspan="1">LPP2.2</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;TGTCTCTCTTTCCGTGCTAGTTC3&#x02032;</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">D8</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;CCGTTTCAGTGGCACGCCCTCTCC3&#x02032;</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Neo</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;ATGGCGATGCCTGCTTGCCGAATA3&#x02032;</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1">Sry</td><td align="left" rowspan="1" colspan="1">Fwd</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;TCATGAGACTGCCAACCACAG3&#x02032;</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Rev</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;CATGACCACCACCACCACCAA3&#x02032;</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1">Tfm<xref ref-type="table-fn" rid="nt101">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">Fwd</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;GTGAAGCAGGTAGCTCTGGG3&#x02032;</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Rev</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;GTTCTCCAGCTTGATACGGG3&#x02032;</named-content></td></tr><tr><td colspan="3" align="left" rowspan="1"><bold>RT-qPCR</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">GAPDH</td><td align="left" rowspan="1" colspan="1">Fwd</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;CCAGAACATCATCCCTGCAT3&#x02032;</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Rev</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;CTTGCCCACAGCCTTGGCAGC3&#x02032;</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1">rpL10A</td><td align="left" rowspan="1" colspan="1">Fwd</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;CGCCGCAAGTTTCTGGAGAC3&#x02032;</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Rev</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;CTTGCCAGCCTTGTTTAGGC3&#x02032;</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1">Lef1</td><td align="left" rowspan="1" colspan="1">Fwd</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;TGAGTGCACGCTAAAGGAGA3&#x02032;</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Rev</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">5&#x02032;ATAATTGTCTCGCGCTGACC3&#x02032;</named-content></td></tr></tbody></table><table-wrap-foot><fn id="nt101"><label>&#x0002a;</label><p>PCR product was digested with <italic>Mwo</italic>I resulting in either a 137 bp (<italic>WT</italic>) or 182 bp (<italic>Tfm</italic>) band.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0005438.s001"><label>Figure S1</label><caption><p><italic>Lef1</italic><sup>&#x02212;/&#x02212;</sup> mice have normal bone development. Histological evaluation of wild type (a&#x02013;e) versus <italic>Lef1</italic><sup>&#x02212;/&#x02212;</sup> (f&#x02013;j) newborn mice. (a,b,f,g) Alizarin red/Alcian blue staining of craniofacial bones. (c,h) Alizarin red/Alcian blue staining of hind limb and vertebrae. (d,i) H-E staining of longitudinal femoral sections. (e,j) Toluidine blue staining of distal femoral growth plates. Representative images are shown. No abnormality was detected in the <italic>Lef1</italic><sup>&#x02212;/&#x02212;</sup> skeletons, except for the previously reported lack of teeth (f) (van Genderen et al. 1994, Genes Dev 8, 2691-703)</p><p>(3.47 MB TIF)</p></caption><media xlink:href="pone.0005438.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005438.s002"><label>Figure S2</label><caption><p>DHT stimulates Lef1 expression <italic>in vitro</italic>. MC3T3-E1 osteoblast cultures maintained in phenol-red free &#x003b1;MEM supplemented with 10&#x00025; charcoal-stripped serum were treated with 30 nM DHT or 100 nM estradiol for 48 hours. Expression of the four members of the Lef/Tcf gene family was assessed by RT-qPCR and corrected for the expression of rpL10A. Bars represent expression levels in the presence of hormone relative to the ethanol vehicle, defined for each gene as 1.</p><p>(0.88 MB TIF)</p></caption><media xlink:href="pone.0005438.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Rudolf Grosschedl (University of Munich and Max-Planck-Institute, Germany) for the <italic>Lef1</italic>-targeted mice.</p></ack><ref-list><title>References</title><ref id="pone.0005438-Miller1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JR</given-names></name><name><surname>Moon</surname><given-names>RT</given-names></name></person-group><year>1996</year><article-title>Signal transduction through beta-catenin and specification of cell fate during embryogenesis.</article-title><source>Genes Dev</source><volume>10</volume><fpage>2527</fpage><lpage>2539</lpage><pub-id pub-id-type="pmid">8895655</pub-id></citation></ref><ref id="pone.0005438-Cadigan1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cadigan</surname><given-names>KM</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><year>1997</year><article-title>Wnt signaling: a common theme in animal development.</article-title><source>Genes Dev</source><volume>11</volume><fpage>3286</fpage><lpage>3305</lpage><pub-id pub-id-type="pmid">9407023</pub-id></citation></ref><ref id="pone.0005438-Bhanot1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhanot</surname><given-names>P</given-names></name><name><surname>Brink</surname><given-names>M</given-names></name><name><surname>Samos</surname><given-names>CH</given-names></name><name><surname>Hsieh</surname><given-names>JC</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><year>1996</year><article-title>A new member of the frizzled family from Drosophila functions as a Wingless receptor.</article-title><source>Nature</source><volume>382</volume><fpage>225</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">8717036</pub-id></citation></ref><ref id="pone.0005438-He1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X</given-names></name><name><surname>Saint-Jeannet</surname><given-names>JP</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Nathans</surname><given-names>J</given-names></name><name><surname>Dawid</surname><given-names>I</given-names></name><etal/></person-group><year>1997</year><article-title>A member of the Frizzled protein family mediating axis induction by Wnt-5A.</article-title><source>Science</source><volume>275</volume><fpage>1652</fpage><lpage>1654</lpage><pub-id pub-id-type="pmid">9054360</pub-id></citation></ref><ref id="pone.0005438-YangSnyder1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang-Snyder</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>JR</given-names></name><name><surname>Brown</surname><given-names>JD</given-names></name><name><surname>Lai</surname><given-names>CJ</given-names></name><name><surname>Moon</surname><given-names>RT</given-names></name></person-group><year>1996</year><article-title>A frizzled homolog functions in a vertebrate Wnt signaling pathway.</article-title><source>Curr Biol</source><volume>6</volume><fpage>1302</fpage><lpage>1306</lpage><pub-id pub-id-type="pmid">8939578</pub-id></citation></ref><ref id="pone.0005438-Pinson1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinson</surname><given-names>KI</given-names></name><name><surname>Brennan</surname><given-names>J</given-names></name><name><surname>Monkley</surname><given-names>S</given-names></name><name><surname>Avery</surname><given-names>BJ</given-names></name><name><surname>Skarnes</surname><given-names>WC</given-names></name></person-group><year>2000</year><article-title>An LDL-receptor-related protein mediates Wnt signalling in mice.</article-title><source>Nature</source><volume>407</volume><fpage>535</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">11029008</pub-id></citation></ref><ref id="pone.0005438-Tamai1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tamai</surname><given-names>K</given-names></name><name><surname>Semenov</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Spokony</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><etal/></person-group><year>2000</year><article-title>LDL-receptor-related proteins in Wnt signal transduction.</article-title><source>Nature</source><volume>407</volume><fpage>530</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">11029007</pub-id></citation></ref><ref id="pone.0005438-Wehrli1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wehrli</surname><given-names>M</given-names></name><name><surname>Dougan</surname><given-names>ST</given-names></name><name><surname>Caldwell</surname><given-names>K</given-names></name><name><surname>O'Keefe</surname><given-names>L</given-names></name><name><surname>Schwartz</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>arrow encodes an LDL-receptor-related protein essential for Wingless signalling.</article-title><source>Nature</source><volume>407</volume><fpage>527</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">11029006</pub-id></citation></ref><ref id="pone.0005438-Hart1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>MJ</given-names></name><name><surname>de los Santos</surname><given-names>R</given-names></name><name><surname>Albert</surname><given-names>IN</given-names></name><name><surname>Rubinfeld</surname><given-names>B</given-names></name><name><surname>Polakis</surname><given-names>P</given-names></name></person-group><year>1998</year><article-title>Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.</article-title><source>Curr Biol</source><volume>8</volume><fpage>573</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">9601641</pub-id></citation></ref><ref id="pone.0005438-Itoh1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Krupnik</surname><given-names>VE</given-names></name><name><surname>Sokol</surname><given-names>SY</given-names></name></person-group><year>1998</year><article-title>Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin.</article-title><source>Curr Biol</source><volume>8</volume><fpage>591</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">9601644</pub-id></citation></ref><ref id="pone.0005438-Ikeda1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>S</given-names></name><name><surname>Kishida</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Murai</surname><given-names>H</given-names></name><name><surname>Koyama</surname><given-names>S</given-names></name><etal/></person-group><year>1998</year><article-title>Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.</article-title><source>Embo J</source><volume>17</volume><fpage>1371</fpage><lpage>1384</lpage><pub-id pub-id-type="pmid">9482734</pub-id></citation></ref><ref id="pone.0005438-Travis1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Travis</surname><given-names>A</given-names></name><name><surname>Amsterdam</surname><given-names>A</given-names></name><name><surname>Belanger</surname><given-names>C</given-names></name><name><surname>Grosschedl</surname><given-names>R</given-names></name></person-group><year>1991</year><article-title>LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function &#x0005b;corrected&#x0005d;.</article-title><source>Genes Dev</source><volume>5</volume><fpage>880</fpage><lpage>894</lpage><pub-id pub-id-type="pmid">1827423</pub-id></citation></ref><ref id="pone.0005438-Waterman1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waterman</surname><given-names>ML</given-names></name><name><surname>Fischer</surname><given-names>WH</given-names></name><name><surname>Jones</surname><given-names>KA</given-names></name></person-group><year>1991</year><article-title>A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer.</article-title><source>Genes Dev</source><volume>5</volume><fpage>656</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">2010090</pub-id></citation></ref><ref id="pone.0005438-vandeWetering1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van de Wetering</surname><given-names>M</given-names></name><name><surname>Oosterwegel</surname><given-names>M</given-names></name><name><surname>Dooijes</surname><given-names>D</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year>1991</year><article-title>Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box.</article-title><source>Embo J</source><volume>10</volume><fpage>123</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">1989880</pub-id></citation></ref><ref id="pone.0005438-Korinek1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korinek</surname><given-names>V</given-names></name><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>Willert</surname><given-names>K</given-names></name><name><surname>Molenaar</surname><given-names>M</given-names></name><name><surname>Roose</surname><given-names>J</given-names></name><etal/></person-group><year>1998</year><article-title>Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse.</article-title><source>Mol Cell Biol</source><volume>18</volume><fpage>1248</fpage><lpage>1256</lpage><pub-id pub-id-type="pmid">9488439</pub-id></citation></ref><ref id="pone.0005438-Bab1"><label>16</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Bab</surname><given-names>I</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>R</given-names></name><name><surname>Hajbi-Yonissi</surname><given-names>C</given-names></name><name><surname>Gabet</surname><given-names>Y</given-names></name></person-group><year>2007</year><source>Micro-Tomographic Atlas of the Mouse Skeleton</source><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name></citation></ref><ref id="pone.0005438-Neu1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neu</surname><given-names>CM</given-names></name><name><surname>Manz</surname><given-names>F</given-names></name><name><surname>Rauch</surname><given-names>F</given-names></name><name><surname>Merkel</surname><given-names>A</given-names></name><name><surname>Schoenau</surname><given-names>E</given-names></name></person-group><year>2001</year><article-title>Bone densities and bone size at the distal radius in healthy children and adolescents: a study using peripheral quantitative computed tomography.</article-title><source>Bone</source><volume>28</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">11182383</pub-id></citation></ref><ref id="pone.0005438-Macdonald1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macdonald</surname><given-names>H</given-names></name><name><surname>Kontulainen</surname><given-names>S</given-names></name><name><surname>Petit</surname><given-names>M</given-names></name><name><surname>Janssen</surname><given-names>P</given-names></name><name><surname>McKay</surname><given-names>H</given-names></name></person-group><year>2006</year><article-title>Bone strength and its determinants in pre- and early pubertal boys and girls.</article-title><source>Bone</source><volume>39</volume><fpage>598</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">16600704</pub-id></citation></ref><ref id="pone.0005438-Glatt1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glatt</surname><given-names>V</given-names></name><name><surname>Canalis</surname><given-names>E</given-names></name><name><surname>Stadmeyer</surname><given-names>L</given-names></name><name><surname>Bouxsein</surname><given-names>ML</given-names></name></person-group><year>2007</year><article-title>Age-related changes in trabecular architecture differ in female and male C57BL/6J mice.</article-title><source>J Bone Miner Res</source><volume>22</volume><fpage>1197</fpage><lpage>1207</lpage><pub-id pub-id-type="pmid">17488199</pub-id></citation></ref><ref id="pone.0005438-Juttner1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juttner</surname><given-names>KV</given-names></name><name><surname>Perry</surname><given-names>MJ</given-names></name></person-group><year>2007</year><article-title>High-dose estrogen-induced osteogenesis is decreased in aged RUNX2(&#x0002b;/&#x02212;) mice.</article-title><source>Bone</source><volume>41</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">17475575</pub-id></citation></ref><ref id="pone.0005438-Pantschenko1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pantschenko</surname><given-names>AG</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Nahounou</surname><given-names>M</given-names></name><name><surname>McCarthy</surname><given-names>MB</given-names></name><name><surname>Stover</surname><given-names>ML</given-names></name><etal/></person-group><year>2005</year><article-title>Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.</article-title><source>J Bone Miner Res</source><volume>20</volume><fpage>1414</fpage><lpage>1429</lpage><pub-id pub-id-type="pmid">16007339</pub-id></citation></ref><ref id="pone.0005438-Glass1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glass</surname><given-names>DA</given-names><suffix>2nd</suffix></name><name><surname>Karsenty</surname><given-names>G</given-names></name></person-group><year>2006</year><article-title>Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.</article-title><source>Curr Top Dev Biol</source><volume>73</volume><fpage>43</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">16782455</pub-id></citation></ref><ref id="pone.0005438-Glass2"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glass</surname><given-names>DA</given-names><suffix>2nd</suffix></name><name><surname>Bialek</surname><given-names>P</given-names></name><name><surname>Ahn</surname><given-names>JD</given-names></name><name><surname>Starbuck</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>MS</given-names></name><etal/></person-group><year>2005</year><article-title>Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.</article-title><source>Dev Cell</source><volume>8</volume><fpage>751</fpage><lpage>764</lpage><pub-id pub-id-type="pmid">15866165</pub-id></citation></ref><ref id="pone.0005438-Holmen1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holmen</surname><given-names>SL</given-names></name><name><surname>Giambernardi</surname><given-names>TA</given-names></name><name><surname>Zylstra</surname><given-names>CR</given-names></name><name><surname>Buckner-Berghuis</surname><given-names>BD</given-names></name><name><surname>Resau</surname><given-names>JH</given-names></name><etal/></person-group><year>2004</year><article-title>Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6.</article-title><source>J Bone Miner Res</source><volume>19</volume><fpage>2033</fpage><lpage>2040</lpage><pub-id pub-id-type="pmid">15537447</pub-id></citation></ref><ref id="pone.0005438-Bennett1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>CN</given-names></name><name><surname>Longo</surname><given-names>KA</given-names></name><name><surname>Wright</surname><given-names>WS</given-names></name><name><surname>Suva</surname><given-names>LJ</given-names></name><name><surname>Lane</surname><given-names>TF</given-names></name><etal/></person-group><year>2005</year><article-title>Regulation of osteoblastogenesis and bone mass by Wnt10b.</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><fpage>3324</fpage><lpage>3329</lpage><pub-id pub-id-type="pmid">15728361</pub-id></citation></ref><ref id="pone.0005438-Kugimiya1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kugimiya</surname><given-names>F</given-names></name><name><surname>Kawaguchi</surname><given-names>H</given-names></name><name><surname>Ohba</surname><given-names>S</given-names></name><name><surname>Kawamura</surname><given-names>N</given-names></name><name><surname>Hirata</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>GSK-3beta controls osteogenesis through regulating Runx2 activity.</article-title><source>PLoS ONE</source><volume>2</volume><fpage>e837</fpage><comment>doi:10.1371/journal.pone.0000837</comment><pub-id pub-id-type="pmid">17786208</pub-id></citation></ref><ref id="pone.0005438-Morvan1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morvan</surname><given-names>F</given-names></name><name><surname>Boulukos</surname><given-names>K</given-names></name><name><surname>Clement-Lacroix</surname><given-names>P</given-names></name><name><surname>Roman Roman</surname><given-names>S</given-names></name><name><surname>Suc-Royer</surname><given-names>I</given-names></name><etal/></person-group><year>2006</year><article-title>Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.</article-title><source>J Bone Miner Res</source><volume>21</volume><fpage>934</fpage><lpage>945</lpage><pub-id pub-id-type="pmid">16753024</pub-id></citation></ref><ref id="pone.0005438-Li1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Maye</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><etal/></person-group><year>2005</year><article-title>Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation.</article-title><source>Nat Genet</source><volume>37</volume><fpage>945</fpage><lpage>952</lpage><pub-id pub-id-type="pmid">16056226</pub-id></citation></ref><ref id="pone.0005438-Bodine1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bodine</surname><given-names>PV</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Kharode</surname><given-names>YP</given-names></name><name><surname>Bex</surname><given-names>FJ</given-names></name><name><surname>Lambert</surname><given-names>AJ</given-names></name><etal/></person-group><year>2004</year><article-title>The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice.</article-title><source>Mol Endocrinol</source><volume>18</volume><fpage>1222</fpage><lpage>1237</lpage><pub-id pub-id-type="pmid">14976225</pub-id></citation></ref><ref id="pone.0005438-Kamiya1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamiya</surname><given-names>N</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Mochida</surname><given-names>Y</given-names></name><name><surname>Yamauchi</surname><given-names>M</given-names></name><etal/></person-group><year>2008</year><article-title>BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.</article-title><source>Development</source><volume>135</volume><fpage>3801</fpage><lpage>3811</lpage><pub-id pub-id-type="pmid">18927151</pub-id></citation></ref><ref id="pone.0005438-Smith1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>E</given-names></name><name><surname>Coetzee</surname><given-names>GA</given-names></name><name><surname>Frenkel</surname><given-names>B</given-names></name></person-group><year>2002</year><article-title>Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>18191</fpage><lpage>18197</lpage><pub-id pub-id-type="pmid">11877389</pub-id></citation></ref><ref id="pone.0005438-Ohnaka1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohnaka</surname><given-names>K</given-names></name><name><surname>Taniguchi</surname><given-names>H</given-names></name><name><surname>Kawate</surname><given-names>H</given-names></name><name><surname>Nawata</surname><given-names>H</given-names></name><name><surname>Takayanagi</surname><given-names>R</given-names></name></person-group><year>2004</year><article-title>Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis.</article-title><source>Biochem Biophys Res Commun</source><volume>318</volume><fpage>259</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">15110782</pub-id></citation></ref><ref id="pone.0005438-Leclerc1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leclerc</surname><given-names>N</given-names></name><name><surname>Noh</surname><given-names>T</given-names></name><name><surname>Cogan</surname><given-names>J</given-names></name><name><surname>Samarawickrama</surname><given-names>DB</given-names></name><name><surname>Smith</surname><given-names>E</given-names></name><etal/></person-group><year>2007</year><article-title>Opposing effects of glucocorticoids and Wnt signaling on Krox20 and mineral deposition in osteoblast cultures.</article-title><source>J Cell Biochem</source></citation></ref><ref id="pone.0005438-Wang1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>FS</given-names></name><name><surname>Lin</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>YJ</given-names></name><name><surname>Wang</surname><given-names>CJ</given-names></name><name><surname>Yang</surname><given-names>KD</given-names></name><etal/></person-group><year>2005</year><article-title>Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass.</article-title><source>Endocrinology</source><volume>146</volume><fpage>2415</fpage><lpage>2423</lpage><pub-id pub-id-type="pmid">15677765</pub-id></citation></ref><ref id="pone.0005438-Armstrong1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>VJ</given-names></name><name><surname>Muzylak</surname><given-names>M</given-names></name><name><surname>Sunters</surname><given-names>A</given-names></name><name><surname>Zaman</surname><given-names>G</given-names></name><name><surname>Saxon</surname><given-names>LK</given-names></name><etal/></person-group><year>2007</year><article-title>Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>20715</fpage><lpage>20727</lpage><pub-id pub-id-type="pmid">17491024</pub-id></citation></ref><ref id="pone.0005438-vanGenderen1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Genderen</surname><given-names>C</given-names></name><name><surname>Okamura</surname><given-names>RM</given-names></name><name><surname>Farinas</surname><given-names>I</given-names></name><name><surname>Quo</surname><given-names>RG</given-names></name><name><surname>Parslow</surname><given-names>TG</given-names></name><etal/></person-group><year>1994</year><article-title>Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice.</article-title><source>Genes Dev</source><volume>8</volume><fpage>2691</fpage><lpage>2703</lpage><pub-id pub-id-type="pmid">7958926</pub-id></citation></ref><ref id="pone.0005438-Galceran1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galceran</surname><given-names>J</given-names></name><name><surname>Farinas</surname><given-names>I</given-names></name><name><surname>Depew</surname><given-names>MJ</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Grosschedl</surname><given-names>R</given-names></name></person-group><year>1999</year><article-title>Wnt3a&#x02212;/&#x02212;like phenotype and limb deficiency in Lef1(&#x02212;/&#x02212;)Tcf1(&#x02212;/&#x02212;) mice.</article-title><source>Genes Dev</source><volume>13</volume><fpage>709</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">10090727</pub-id></citation></ref><ref id="pone.0005438-Okamura1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okamura</surname><given-names>RM</given-names></name><name><surname>Sigvardsson</surname><given-names>M</given-names></name><name><surname>Galceran</surname><given-names>J</given-names></name><name><surname>Verbeek</surname><given-names>S</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><etal/></person-group><year>1998</year><article-title>Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1.</article-title><source>Immunity</source><volume>8</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">9462507</pub-id></citation></ref><ref id="pone.0005438-Staal1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Staal</surname><given-names>FJ</given-names></name><name><surname>Meeldijk</surname><given-names>J</given-names></name><name><surname>Moerer</surname><given-names>P</given-names></name><name><surname>Jay</surname><given-names>P</given-names></name><name><surname>van de Weerdt</surname><given-names>BC</given-names></name><etal/></person-group><year>2001</year><article-title>Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription.</article-title><source>Eur J Immunol</source><volume>31</volume><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">11265645</pub-id></citation></ref><ref id="pone.0005438-Galceran2"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galceran</surname><given-names>J</given-names></name><name><surname>Miyashita-Lin</surname><given-names>EM</given-names></name><name><surname>Devaney</surname><given-names>E</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name><name><surname>Grosschedl</surname><given-names>R</given-names></name></person-group><year>2000</year><article-title>Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1.</article-title><source>Development</source><volume>127</volume><fpage>469</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">10631168</pub-id></citation></ref><ref id="pone.0005438-Babij1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Babij</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Small</surname><given-names>C</given-names></name><name><surname>Kharode</surname><given-names>Y</given-names></name><name><surname>Yaworsky</surname><given-names>PJ</given-names></name><etal/></person-group><year>2003</year><article-title>High bone mass in mice expressing a mutant LRP5 gene.</article-title><source>J Bone Miner Res</source><volume>18</volume><fpage>960</fpage><lpage>974</lpage><pub-id pub-id-type="pmid">12817748</pub-id></citation></ref><ref id="pone.0005438-Akhter1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akhter</surname><given-names>MP</given-names></name><name><surname>Wells</surname><given-names>DJ</given-names></name><name><surname>Short</surname><given-names>SJ</given-names></name><name><surname>Cullen</surname><given-names>DM</given-names></name><name><surname>Johnson</surname><given-names>ML</given-names></name><etal/></person-group><year>2004</year><article-title>Bone biomechanical properties in LRP5 mutant mice.</article-title><source>Bone</source><volume>35</volume><fpage>162</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">15207752</pub-id></citation></ref><ref id="pone.0005438-Sawakami1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sawakami</surname><given-names>K</given-names></name><name><surname>Robling</surname><given-names>AG</given-names></name><name><surname>Ai</surname><given-names>M</given-names></name><name><surname>Pitner</surname><given-names>ND</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><etal/></person-group><year>2006</year><article-title>The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>23698</fpage><lpage>23711</lpage><pub-id pub-id-type="pmid">16790443</pub-id></citation></ref><ref id="pone.0005438-Wu1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Torchia</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>W</given-names></name><name><surname>Lane</surname><given-names>NE</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name><etal/></person-group><year>2007</year><article-title>Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency.</article-title><source>PLoS ONE</source><volume>2</volume><fpage>e586</fpage><comment>doi:10.1371/journal.pone.0000586</comment><pub-id pub-id-type="pmid">17611621</pub-id></citation></ref><ref id="pone.0005438-Hill1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>TP</given-names></name><name><surname>Spater</surname><given-names>D</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Birchmeier</surname><given-names>W</given-names></name><name><surname>Hartmann</surname><given-names>C</given-names></name></person-group><year>2005</year><article-title>Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.</article-title><source>Dev Cell</source><volume>8</volume><fpage>727</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">15866163</pub-id></citation></ref><ref id="pone.0005438-DeMambro1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeMambro</surname><given-names>VE</given-names></name><name><surname>Clemmons</surname><given-names>DR</given-names></name><name><surname>Horton</surname><given-names>LG</given-names></name><name><surname>Bouxsein</surname><given-names>ML</given-names></name><name><surname>Wood</surname><given-names>TL</given-names></name><etal/></person-group><year>2008</year><article-title>Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice.</article-title><source>Endocrinology</source><volume>149</volume><fpage>2051</fpage><lpage>2061</lpage><pub-id pub-id-type="pmid">18276763</pub-id></citation></ref><ref id="pone.0005438-Pennypacker1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pennypacker</surname><given-names>B</given-names></name><name><surname>Shea</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Masarachia</surname><given-names>P</given-names></name><name><surname>Saftig</surname><given-names>P</given-names></name><etal/></person-group><year>2008</year><article-title>Bone density, strength, and formation in adult cathepsin K (&#x02212;/&#x02212;) mice.</article-title><source>Bone</source></citation></ref><ref id="pone.0005438-Hoeflich1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoeflich</surname><given-names>KP</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Rubie</surname><given-names>EA</given-names></name><name><surname>Tsao</surname><given-names>MS</given-names></name><name><surname>Jin</surname><given-names>O</given-names></name><etal/></person-group><year>2000</year><article-title>Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.</article-title><source>Nature</source><volume>406</volume><fpage>86</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">10894547</pub-id></citation></ref><ref id="pone.0005438-Liu1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>XH</given-names></name><name><surname>Kirschenbaum</surname><given-names>A</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Aaronson</surname><given-names>SA</given-names></name><etal/></person-group><year>2007</year><article-title>Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells.</article-title><source>Cancer Res</source><volume>67</volume><fpage>5747</fpage><lpage>5753</lpage><pub-id pub-id-type="pmid">17575141</pub-id></citation></ref><ref id="pone.0005438-Liu2"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>XH</given-names></name><name><surname>Kirschenbaum</surname><given-names>A</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Levine</surname><given-names>AC</given-names></name></person-group><year>2007</year><article-title>Androgens Promote Preosteoblast Differentiation via Activation of the Canonical Wnt Signaling Pathway.</article-title><source>Ann N Y Acad Sci</source><volume>1116</volume><fpage>423</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">17646262</pub-id></citation></ref><ref id="pone.0005438-Singh1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Artaza</surname><given-names>JN</given-names></name><name><surname>Taylor</surname><given-names>WE</given-names></name><name><surname>Braga</surname><given-names>M</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><etal/></person-group><year>2006</year><article-title>Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors.</article-title><source>Endocrinology</source><volume>147</volume><fpage>141</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">16210377</pub-id></citation></ref><ref id="pone.0005438-Lyon1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname><given-names>MF</given-names></name><name><surname>Hawkes</surname><given-names>SG</given-names></name></person-group><year>1970</year><article-title>X-linked gene for testicular feminization in the mouse.</article-title><source>Nature</source><volume>227</volume><fpage>1217</fpage><lpage>1219</lpage><pub-id pub-id-type="pmid">5452809</pub-id></citation></ref><ref id="pone.0005438-Lyon2"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname><given-names>MF</given-names></name></person-group><year>1961</year><article-title>Gene action in the X-chromosome of the mouse (Mus musculus L.).</article-title><source>Nature</source><volume>190</volume><fpage>372</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">13764598</pub-id></citation></ref><ref id="pone.0005438-Vandenput1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vandenput</surname><given-names>L</given-names></name><name><surname>Swinnen</surname><given-names>JV</given-names></name><name><surname>Boonen</surname><given-names>S</given-names></name><name><surname>Van Herck</surname><given-names>E</given-names></name><name><surname>Erben</surname><given-names>RG</given-names></name><etal/></person-group><year>2004</year><article-title>Role of the androgen receptor in skeletal homeostasis: the androgen-resistant testicular feminized male mouse model.</article-title><source>J Bone Miner Res</source><volume>19</volume><fpage>1462</fpage><lpage>1470</lpage><pub-id pub-id-type="pmid">15312246</pub-id></citation></ref><ref id="pone.0005438-Matsumoto1"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>C</given-names></name><name><surname>Inada</surname><given-names>M</given-names></name><name><surname>Toda</surname><given-names>K</given-names></name><name><surname>Miyaura</surname><given-names>C</given-names></name></person-group><year>2006</year><article-title>Estrogen and androgen play distinct roles in bone turnover in male mice before and after reaching sexual maturity.</article-title><source>Bone</source><volume>38</volume><fpage>220</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">16213803</pub-id></citation></ref><ref id="pone.0005438-Dubrow1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dubrow</surname><given-names>SA</given-names></name><name><surname>Hruby</surname><given-names>PM</given-names></name><name><surname>Akhter</surname><given-names>MP</given-names></name></person-group><year>2007</year><article-title>Gender specific LRP5 influences on trabecular bone structure and strength.</article-title><source>J Musculoskelet Neuronal Interact</source><volume>7</volume><fpage>166</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">17627087</pub-id></citation></ref><ref id="pone.0005438-Yadav1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>VK</given-names></name><name><surname>Ryu</surname><given-names>JH</given-names></name><name><surname>Suda</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>KF</given-names></name><name><surname>Gingrich</surname><given-names>JA</given-names></name><etal/></person-group><year>2008</year><article-title>Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.</article-title><source>Cell</source><volume>135</volume><fpage>825</fpage><lpage>837</lpage><pub-id pub-id-type="pmid">19041748</pub-id></citation></ref><ref id="pone.0005438-Migliaccio1"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Migliaccio</surname><given-names>A</given-names></name><name><surname>Varricchio</surname><given-names>L</given-names></name><name><surname>De Falco</surname><given-names>A</given-names></name><name><surname>Castoria</surname><given-names>G</given-names></name><name><surname>Arra</surname><given-names>C</given-names></name><etal/></person-group><year>2007</year><article-title>Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth.</article-title><source>Oncogene</source><volume>26</volume><fpage>6619</fpage><lpage>6629</lpage><pub-id pub-id-type="pmid">17486077</pub-id></citation></ref><ref id="pone.0005438-Kang1"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>HY</given-names></name><name><surname>Cho</surname><given-names>CL</given-names></name><name><surname>Huang</surname><given-names>KL</given-names></name><name><surname>Wang</surname><given-names>JC</given-names></name><name><surname>Hu</surname><given-names>YC</given-names></name><etal/></person-group><year>2004</year><article-title>Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts.</article-title><source>J Bone Miner Res</source><volume>19</volume><fpage>1181</fpage><lpage>1190</lpage><pub-id pub-id-type="pmid">15177002</pub-id></citation></ref><ref id="pone.0005438-Smith2"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>E</given-names></name><name><surname>Frenkel</surname><given-names>B</given-names></name></person-group><year>2005</year><article-title>Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>2388</fpage><lpage>2394</lpage><pub-id pub-id-type="pmid">15537647</pub-id></citation></ref><ref id="pone.0005438-Nantermet1"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nantermet</surname><given-names>PV</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Hodor</surname><given-names>P</given-names></name><name><surname>Holder</surname><given-names>D</given-names></name><etal/></person-group><year>2004</year><article-title>Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>1310</fpage><lpage>1322</lpage><pub-id pub-id-type="pmid">14576152</pub-id></citation></ref><ref id="pone.0005438-Kahler1"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kahler</surname><given-names>RA</given-names></name><name><surname>Galindo</surname><given-names>M</given-names></name><name><surname>Lian</surname><given-names>J</given-names></name><name><surname>Stein</surname><given-names>GS</given-names></name><name><surname>van Wijnen</surname><given-names>AJ</given-names></name><etal/></person-group><year>2006</year><article-title>Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts.</article-title><source>J Cell Biochem</source><volume>97</volume><fpage>969</fpage><lpage>983</lpage><pub-id pub-id-type="pmid">16267835</pub-id></citation></ref><ref id="pone.0005438-Kahler2"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kahler</surname><given-names>RA</given-names></name><name><surname>Westendorf</surname><given-names>JJ</given-names></name></person-group><year>2003</year><article-title>Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>11937</fpage><lpage>11944</lpage><pub-id pub-id-type="pmid">12551949</pub-id></citation></ref><ref id="pone.0005438-Mishina1"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mishina</surname><given-names>Y</given-names></name><name><surname>Starbuck</surname><given-names>MW</given-names></name><name><surname>Gentile</surname><given-names>MA</given-names></name><name><surname>Fukuda</surname><given-names>T</given-names></name><name><surname>Kasparcova</surname><given-names>V</given-names></name><etal/></person-group><year>2004</year><article-title>Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>27560</fpage><lpage>27566</lpage><pub-id pub-id-type="pmid">15090551</pub-id></citation></ref><ref id="pone.0005438-Bajayo1"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bajayo</surname><given-names>A</given-names></name><name><surname>Goshen</surname><given-names>I</given-names></name><name><surname>Feldman</surname><given-names>S</given-names></name><name><surname>Csernus</surname><given-names>V</given-names></name><name><surname>Iverfeldt</surname><given-names>K</given-names></name><etal/></person-group><year>2005</year><article-title>Central IL-1 receptor signaling regulates bone growth and mass.</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><fpage>12956</fpage><lpage>12961</lpage><pub-id pub-id-type="pmid">16126903</pub-id></citation></ref><ref id="pone.0005438-Yirmiya1"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yirmiya</surname><given-names>R</given-names></name><name><surname>Goshen</surname><given-names>I</given-names></name><name><surname>Bajayo</surname><given-names>A</given-names></name><name><surname>Kreisel</surname><given-names>T</given-names></name><name><surname>Feldman</surname><given-names>S</given-names></name><etal/></person-group><year>2006</year><article-title>Depression induces bone loss through stimulation of the sympathetic nervous system.</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>16876</fpage><lpage>16881</lpage><pub-id pub-id-type="pmid">17075068</pub-id></citation></ref><ref id="pone.0005438-Ruegsegger1"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruegsegger</surname><given-names>P</given-names></name><name><surname>Koller</surname><given-names>B</given-names></name><name><surname>Muller</surname><given-names>R</given-names></name></person-group><year>1996</year><article-title>A microtomographic system for the nondestructive evaluation of bone architecture.</article-title><source>Calcif Tissue Int</source><volume>58</volume><fpage>24</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">8825235</pub-id></citation></ref><ref id="pone.0005438-Hildebrand1"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hildebrand</surname><given-names>T</given-names></name><name><surname>Laib</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>R</given-names></name><name><surname>Dequeker</surname><given-names>J</given-names></name><name><surname>Ruegsegger</surname><given-names>P</given-names></name></person-group><year>1999</year><article-title>Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus.</article-title><source>J Bone Miner Res</source><volume>14</volume><fpage>1167</fpage><lpage>1174</lpage><pub-id pub-id-type="pmid">10404017</pub-id></citation></ref><ref id="pone.0005438-Erlebacher1"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erlebacher</surname><given-names>A</given-names></name><name><surname>Derynck</surname><given-names>R</given-names></name></person-group><year>1996</year><article-title>Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.</article-title><source>J Cell Biol</source><volume>132</volume><fpage>195</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">8567723</pub-id></citation></ref><ref id="pone.0005438-Parfitt1"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parfitt</surname><given-names>AM</given-names></name><name><surname>Drezner</surname><given-names>MK</given-names></name><name><surname>Glorieux</surname><given-names>FH</given-names></name><name><surname>Kanis</surname><given-names>JA</given-names></name><name><surname>Malluche</surname><given-names>H</given-names></name><etal/></person-group><year>1987</year><article-title>Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.</article-title><source>J Bone Miner Res</source><volume>2</volume><fpage>595</fpage><lpage>610</lpage><pub-id pub-id-type="pmid">3455637</pub-id></citation></ref><ref id="pone.0005438-Leclerc2"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leclerc</surname><given-names>N</given-names></name><name><surname>Noh</surname><given-names>T</given-names></name><name><surname>Cogan</surname><given-names>J</given-names></name><name><surname>Samarawickrama</surname><given-names>DB</given-names></name><name><surname>Smith</surname><given-names>E</given-names></name><etal/></person-group><year>2008</year><article-title>Opposing effects of glucocorticoids and Wnt signaling on Krox20 and mineral deposition in osteoblast cultures.</article-title><source>J Cell Biochem</source><volume>103</volume><fpage>1938</fpage><lpage>1951</lpage><pub-id pub-id-type="pmid">17973254</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>BF's group was supported by the Arthritis Foundation (Atlanta, GA), by the NIH (AR047052), and by the J. Harold and Edna L. LaBriola Chair in Genetic Orthopaedic Research at the University of Southern California. IB's team was supported by the NIH (AR047052). JW's group was supported by the Canadian Institutes of Health Research (MOP#74711). TK and RM were supported by the Swiss National Science Foundation (Grants FP 620-58097.99 and PP-104317/1). YG was partly supported by a Meyer Young Investigator Fellowship from the Arthritis Foundation Southern California Chapter. The use of the microCAT II image system at the USC Molecular Imaging Center was made possible by a 2005 NCRR shared instrumentation award. The experiments were conducted in part in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 (RR10600-01, CA62528-01, RR14514-01) from the NIH/NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 